CKAP4 biomarker identifies stage I lung cancer
Scientists in Japan have discovered a promising new biomarker – cytoskeleton-associated protein 4 (CKAP4) – for lung cancer, potentially transforming the way the disease is diagnosed and treated.
List view / Grid view
News
Cellular reprogramming promotes muscle regeneration in injured mice
Scientists have developed a simple and robust approach for directly reprogramming mature skin cells into immature muscle cells...
Study provides insight into blood signatures of inflammation
A new study has identified a pattern of inflammation associated with cardio-metabolic risks...
Leukaemia protective role of Y chromosome gene discovered
Scientists have discovered the first leukaemia protective gene that is specific to the male-only Y chromosome...
ELRIG UK hosts inaugural Discovery Technologies event
ELRIG (European Laboratory Research & Innovation Group) has announced its first Discovery Technologies meeting, which will take place at Alderley Park, located near Macclesfield in Cheshire.
Cambinol halts spread of toxic protein associated with Alzheimer’s progression
Research could help lead to the design of drugs that slow neurodegeneration...
Migraine study provides insight into the disease
By studying migraine patients researchers have identified over 40 significant genetic risk variants that predispose individuals to migraines...
CAR-T immunotherapy eliminates metastatic colorectal cancer in mice
A CAR-T-based immunotherapy successfully kills tumours and prevents metastatic growth, in final preclinical tests before human trials...
Study offers new approach to starve p53 deficient tumours
Sanford Prebys Medical Discovery Institute (SBP) researchers recently discovered an alternative metabolic pathway that might be used by cancer cells to survive nutrient deprivation.
Controlling immune cell migration as therapy for heart disease
Researchers in the United States find that the location of the body’s immune cells correlates precisely with their function related to heart disease.
Scientists study long-term effects of stem cell treatment for AICLI
Researchers in China have conducted a unique study investigating the long-term effects of stem cells to treat angiitis-induced critical limb ischemia (AICLI).
Lymphatic endothelial cells are found to promote the spread of melanoma
Scientists have investigated the mechanisms by which the lymphatic endothelial cells modulate metastasis in melanoma, providing new targets for therapy development.
Research identifies novel unconventional type of immune cell capable of fighting viral infections
Research led by the University of Birmingham has identified a novel unconventional type of immune cell capable of fighting viral infections.
Genomic analysis unravels complexities of the most common form of lymphoma
Genomic analysis has shown a better framework for understanding lymphoma’s many forms and will help to predict individual patient outcomes and guide personalised treatment.
T cell populations in CLL patients indicate potential success of CAR-T cell therapy
Researchers have discovered the reason why some patients with advanced chronic lymphocytic leukaemia (CLL) don't respond to chimeric antigen receptor (CAR) T cell therapy...
